195 related articles for article (PubMed ID: 2425057)
1. Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages.
Sutherland JA; Turner AR; Mannoni P; McGann LE; Turc JM
J Biol Response Mod; 1986 Jun; 5(3):250-62. PubMed ID: 2425057
[TBL] [Abstract][Full Text] [Related]
2. Expression of megakaryocytic and erythroid properties in human leukemic cells.
Tani T; Ylänne J; Virtanen I
Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
[TBL] [Abstract][Full Text] [Related]
3. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells.
Niitsu N; Yamamoto-Yamaguchi Y; Miyoshi H; Shimizu K; Ohki M; Umeda M; Honma Y
Cell Growth Differ; 1997 Mar; 8(3):319-26. PubMed ID: 9056674
[TBL] [Abstract][Full Text] [Related]
4. Induction of B-lymphocyte antigens on the chronic myeloid leukemic cell line K562 using sodium butyrate.
Fraser JK; Berridge MV
Exp Hematol; 1987 May; 15(4):406-13. PubMed ID: 2952519
[TBL] [Abstract][Full Text] [Related]
5. HLA class-I and class-II antigen expression by human leukemic K562 cells and by Burkitt-K562 hybrids: modulation by differentiation inducers and interferon.
Garson D; Dokhélar MC; Wakasugi H; Mishal Z; Tursz T
Exp Hematol; 1985 Oct; 13(9):885-90. PubMed ID: 3930277
[TBL] [Abstract][Full Text] [Related]
6. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
Santoli D; Francis MK; Matera L; Ferrero D
J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106
[TBL] [Abstract][Full Text] [Related]
7. Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental model for hemopoietic lineage restriction.
Green AR; Rockman S; DeLuca E; Begley CG
Exp Hematol; 1993 Apr; 21(4):525-31. PubMed ID: 8462662
[TBL] [Abstract][Full Text] [Related]
8. The human promyelocytic HL60 cell line: a model of myeloid cell differentiation using dimethylsulphoxide, phorbol ester and butyrate.
Ahmed N; Williams JF; Weidemann MJ
Biochem Int; 1991 Feb; 23(3):591-602. PubMed ID: 1652248
[TBL] [Abstract][Full Text] [Related]
9. [Changes in the K562 cell sensitivity to nonspecific lysis by human and rat leukocytes under the influence of sodium butyrate, dimethyl sulfoxide and phorbol-12-myristate-13-acetate].
Anisimov AG; Bolotnikov IA; Volkova TO
Ontogenez; 2000; 31(1):47-52. PubMed ID: 10732363
[TBL] [Abstract][Full Text] [Related]
10. K562 erythroleukemia cells express cytokeratins 8, 18, and 19 and epithelial membrane antigen that disappear after induced differentiation.
Järvinen M; Andersson LC; Virtanen I
J Cell Physiol; 1990 May; 143(2):310-20. PubMed ID: 1692028
[TBL] [Abstract][Full Text] [Related]
11. Cytochemical characteristics of leukopoietic differentiation in murine erythroleukemic (Friend) cells.
Fioritoni G; Bertolini L; Torlontano G; Revoltella R
Cancer Res; 1980 Mar; 40(3):866-72. PubMed ID: 6937242
[TBL] [Abstract][Full Text] [Related]
12. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
Chen YL; Wu RT
Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
[TBL] [Abstract][Full Text] [Related]
13. Single K562 human leukemia cells express and are inducible for both erythroid and megakaryocytic antigens.
Rowley PT; Farley BA; LaBella S; Giuliano R; Leary JF
Int J Cell Cloning; 1992 Jul; 10(4):232-40. PubMed ID: 1645031
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenocarcinoma cells.
Tsao D; Morita A; Bella A; Luu P; Kim YS
Cancer Res; 1982 Mar; 42(3):1052-8. PubMed ID: 7059970
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
Stöckbauer P; Malasková V; Soucek J; Chudomel V
Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
[TBL] [Abstract][Full Text] [Related]
16. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells.
Delgado MD; Quincoces AF; Gómez-Casares MT; Martínez CA; Cuadrado MA; Richard C; León J
Cancer Res; 1992 Nov; 52(21):5979-84. PubMed ID: 1394224
[TBL] [Abstract][Full Text] [Related]
18. Iron deprivation blocks multilineage haematopoietic differentiation by inhibiting induction of p21(WAF1/CIP1).
Alcantara O; Boldt DH
Br J Haematol; 2007 May; 137(3):252-61. PubMed ID: 17408467
[TBL] [Abstract][Full Text] [Related]
19. Distribution of a hematopoietic-specific differentiation antigen of K562 cells in the human myeloid and lymphoid cell lineages.
Clarke BJ; Liao SK; Leeds C; Soamboonsrup P; Neame PB
Cancer Res; 1987 Aug; 47(16):4254-9. PubMed ID: 3475169
[TBL] [Abstract][Full Text] [Related]
20. Alteration in insulin receptor expression accompanying differentiation of HL-60 leukemia cells.
Chaplinski TJ; Bennett TE; Caro JF
Cancer Res; 1986 Mar; 46(3):1203-7. PubMed ID: 3002611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]